Short-Term Cardiovascular Effects of E-Cigarettes: Influence of E-Liquid pH

NACompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

January 4, 2021

Primary Completion Date

July 31, 2024

Study Completion Date

July 31, 2024

Conditions
Cardiovascular Risk FactorNicotine Dependence
Interventions
OTHER

Electronic Cigarette

E-cigarette Device: The delivery device will be a variable wattage all-in-one device with operating wattage of 7.0 - 75.0 W. The device will be set at 10 watts for the study visits.

Trial Locations (2)

94110

Zuckerberg San Francisco General Hospital, San Francisco

94143

University of California, San Francisco, San Francisco

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

Food and Drug Administration (FDA)

FED

collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

University of California, San Francisco

OTHER

NCT04449510 - Short-Term Cardiovascular Effects of E-Cigarettes: Influence of E-Liquid pH | Biotech Hunter | Biotech Hunter